SCHEMBL10750366

SCHEMBL10750366

COc1cc(Cl)cc(CCC(C)=O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
MAOA P21397 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A3 Q01959 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CNR1 P21554 1/20 0.45
FFAR4 Q5NUL3 1/20 0.43
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MARS1 P56192 2/20 0.41
HSD17B1 P14061 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16054397 0.88 KDM4E (0.62) NPC1RAB9AKDM4ELMNATP53
SCHEMBL3940515 0.85 CNR1 (0.47) KDM4EMAPTCNR1FFAR4NFKB1
SCHEMBL13235717 0.84 ALDH1A1 (0.52) NPC1RAB9AKDM4ELMNATP53
SCHEMBL21102126 0.83 MARS1 (0.43) NPC1RAB9AKDM4ELMNATP53
SCHEMBL10754632 0.78 LMNA (0.51) NPC1RAB9AKDM4ELMNATP53
SCHEMBL10752739 0.78 NPC1 (0.51) NPC1RAB9AKDM4ELMNATP53
SCHEMBL10750814 0.78 LMNA (0.51) NPC1RAB9AKDM4ELMNATP53
SCHEMBL15994904 0.77 KDM4E (0.50) NPC1RAB9AKDM4ELMNATP53
SCHEMBL10752951 0.77 ALDH1A1 (0.46) NPC1RAB9AKDM4ELMNATP53
SCHEMBL14288599 0.77 PTGS2 (0.47) CYP3A4CNR1FFAR4ALDH1A1MARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4647579-A Circulation active novel substituted 4-hydroxy-benzopyrans BAYER AKTIENGESELLSCHAFT (DE) 1987-03-03 US disclosed